(Q39780098)

14 September 2017

1 reference

title

Clinical Pharmacokinetics of Hypolipidaemic Drugs (English)

1 reference

10.2165/00003088-197803060-00001

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-197803060-00001

26 June 2022

1 reference

10.2165/00003088-197803060-00001

https://api.crossref.org/works/10.2165/00003088-197803060-00001

26 June 2022

author name string

R. Gugler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363332

26 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=363332

26 June 2022

publication date

1 November 1978

1 reference

Clinical Pharmacokinetics

14 September 2017

1 reference

14 September 2017

3

1 reference

14 September 2017

425-439

1 reference

14 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-197803060-00001

14 September 2017

0 references

cites work

The Influence of Cholestyramine on Thyroxine Absorption

1 reference

12 December 2020

Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs

1 reference

12 December 2020

Metabolism of nicotinic acid and related compounds in man and rat.

1 reference

12 December 2020

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

12 December 2020

INITIAL DISTRIBUTION IN MICE OF 3H-LABELED NICOTINIC ACID STUDIED WITH AUTORADIOGRAPHY

1 reference

12 December 2020

Pharmacokinetics of drugs in patients with the nephrotic syndrome

1 reference

12 December 2020

Drug protein binding and the nephrotic syndrome

1 reference

12 December 2020

Urinary metabolites of 14C-labeled thyroxine in man

1 reference

12 December 2020

β-Sitosterolemia and Xanthomatosis

1 reference

12 December 2020

Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

1 reference

12 December 2020

Control of clofibrate toxicity in uremic hypertriglyceridemia

1 reference

12 December 2020

Simulation of the Thyroid Hormone-Binding Protein Interactions in Human Plasma1

1 reference

12 December 2020

On the absorption, excretion and metabolism of pentaerythritoltetranicotinate.

1 reference

12 December 2020

Classification of hyperlipidaemias and hyperlipoproteinaemias

1 reference

12 December 2020

Lack of Effect of Cholestyramine on the Pharmacokinetics of Clofibrate in Man

1 reference

12 December 2020

Effects of ethylp-chlorophenoxyisobutyrate on biliary secretion of bile acids, cholesterol and phosphatidyl choline

1 reference

12 December 2020

Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region

1 reference

12 December 2020

GI absorption of niacin in humans

1 reference

12 December 2020

Renal mechanisms for the excretion of nicotinic acid

1 reference

12 December 2020

Clofibrate-induced muscle damage in patients with chronic renal failure

1 reference

12 December 2020

Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians

1 reference

12 December 2020

Drug treatment of hyperlipidemia

1 reference

12 December 2020

Macromolecular drugs I: long-lasting antilipolytic activity of nicotinic acid bound to a polymer

1 reference

12 December 2020

Pharmacokinetics in patients with cardiac failure

1 reference

12 December 2020

Clofibrate in hemodialyzed patients

1 reference

12 December 2020

Pharmacokinetics of Clofibrate and Chlorophenoxy Isobutyric Acid. I. Cross-over Studies on Human Volunteers

1 reference

12 December 2020

A rapid gas chromatographic method for the determination of chlorophenoxyisobutyric acid in plasma and urine

1 reference

12 December 2020

Nicotinic acid blood levels after application of xanthinolnicotinate in a new galenic retard preparation

1 reference

12 December 2020

Absorption fo Oral Thyroxine in Hypothyroid and Normal Man

1 reference

12 December 2020

Change in receptor site affinity: a proposed explanation for the potentiating effect of D-thyroxine on the anticoagulant response to warfarin

1 reference

12 December 2020

The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man

1 reference

12 December 2020

ON THE ELIMINATION OF UNABSORBED HEXANICOTINIC ACID ESTERS OF MESO-INOSITOL IN THE FECES

1 reference

12 December 2020

Blood- and Serum-levels of Water-soluble Vitamins in Man and Animals

1 reference

12 December 2020

Untoward effects of clofibrate in hemodialyzed patients

1 reference

12 December 2020

Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Clearance concepts in pharmacokinetics

1 reference

12 December 2020

Effect of Plasma Protein Binding on Elimination of Warfarin

1 reference

12 December 2020

The management of hyperlipidemia: whether, rather than how

1 reference

12 December 2020

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

1 reference

12 December 2020

Comparison between the Absorption of Nicotinic Acid and Pentaerythritol Tetranicotinate (Perycit®) from Ordinary and Enterocoated Tablets

1 reference

12 December 2020

Investigation of the Mechanism of Action of Nicotinic Acid on Serum Lipid Levels in Man

1 reference

12 December 2020

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

1 reference

12 December 2020

The interaction between cholestyramine and drugs

1 reference

12 December 2020

N-Methyl-4-pyridone-5-carboxamide as a metabolite of nicotinic acid in man and monkey

1 reference

12 December 2020

Interaction of warfarin and nonsystemic gastrointestinal drugs

1 reference

12 December 2020

Treatment of hyperlipidemia

1 reference

12 December 2020

Comparative pharmacokinetic study of 2 galenic forms of nicotinic acid

1 reference

12 December 2020

Protein Binding and Kinetics of Drugs in Liver Diseases

1 reference

12 December 2020

Absorption of Oral Thyroxine in Man

1 reference

12 December 2020

Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease

1 reference

12 December 2020

Acute effect of a sustained release pyridyl carbinol preparation, ronicol retard, on plasma free fatty acids

1 reference

12 December 2020

The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man

1 reference

12 December 2020

Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters

1 reference

12 December 2020

Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat

1 reference

12 December 2020

The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone

1 reference

12 December 2020

Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia

1 reference

12 December 2020

A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man

1 reference

12 December 2020

Lipid lowering drugs and hyperlipidaemia

1 reference

12 December 2020

The Effect of Nicotinic Acid on the Plasma Free Fatty Acids Demonstration of a Metabolic Type of Sympathicolysis

1 reference

12 December 2020

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group

1 reference

12 December 2020

10.2165/00003088-197803060-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference